Clinical Trials Logo

HEMNOS clinical trials

View clinical trials related to HEMNOS.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04634357 Recruiting - Liver Cancer Clinical Trials

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

ARYA-2
Start date: July 19, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

Open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety/tolerability and determine the recommended Phase II Dose (RP2D) of ET140203 T-cells in pediatric subjects who are AFP-positive/HLA-A2-positive and have relapsed/refractory HB, HCN-NOS, or HCC.